We are live on ! Find out more
VIVS

VivoSim Labs

23 hedge funds and large institutions have $143K invested in VivoSim Labs in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.23% more ownership

Funds ownership: 1.35%3.58% (+2.2%)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

21% less funds holding

Funds holding: 2923 (-6)

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

88% less capital invested

Capital invested by funds: $1.15M → $143K (-$1M)

Holders
23
Holders Change
-6
Holders Change %
-20.69%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
6
Closed
10
Calls
Puts
Net Calls
Net Calls Change

VIVS Hedge Fund Activity: Q1 2025 in Review

23 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q1 2025, worth a combined $143K — down 88% from $1.15M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of VIVS and 4 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 6 added.

The largest buyer was Vanguard Group, adding an estimated $62.7K. The largest seller was Armistice Capital, exiting entirely with an estimated $754K sold.

  • 23 institutional investors held VivoSim Labs (VIVS) as of Q1 2025, down from 29 in Q4 2024.
  • Funds reported $143K of VivoSim Labs stock for Q1 2025, down 88% quarter-over-quarter.
  • 4 funds opened new VivoSim Labs positions in Q1 2025 and 10 closed out, a net change of -6 holders.
  • The largest VivoSim Labs buyer in Q1 2025 was Vanguard Group, an estimated $62.7K added.
  • The largest VivoSim Labs seller in Q1 2025 was Armistice Capital, an estimated $754K sold.

Based on aggregated 13F filings for Q1 2025.